CVS · CVS Health Corp
United States · RS rating 53 · As of 2026-10-14
| Price | 90.39 USD |
|---|---|
| 1-day change | +3.2% |
| RS rating (overall / 1M / 3M / 12M) | 53 / 40 / 24 / 70 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 43 / 29 / 61 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | +173.5% |
| Sales growth Q/Q | +2.7% |
| Distance from 52-week high | +18.3% |
| Market cap (USD) | $101.1B |